全球儿科心肌肌钙蛋白检测现状:IFCC 调查揭示标准化需求与可及性挑战
国际临床化学与检验医学联合会(IFCC)儿科检验医学新兴技术委员会于2025年开展电子调查,覆盖48个国家439份回复(330份符合纳入标准),评估儿科心肌肌钙蛋白(cTn)检测的全球可及性、使用模式与挑战。结果显示58.4%的受访者提供院内cTn检测,其中65.5%缺乏儿科特异性参考区间,且现有区间在来源、数值和性别分层上差异显著。受访者一致认为缺乏验证的儿科参考区间、明确临床指南和标准化检测指征是主要障碍。
要点
- 全球儿科cTn检测可及性有限,仅58.4%受访者提供院内检测。
- 提供儿科参考区间的实验室中,来源、数值和性别分层差异显著。
- 缺乏验证的儿科参考区间和临床指南是主要障碍。
核心结论
- 缺乏基于结局的稳健儿科参考区间、有限临床指导和判读框架,是全球儿科cTn检测有效合理应用的关键障碍。
研究设计与样本
- IFCC儿科检验医学新兴技术委员会于2025年开展电子调查,为期一个月,含19个问题,面向实验室专业人员和儿科临床医生。
- 共收集48个国家439份回复,330份符合纳入标准;大多数受访者为实验室专家,临床医生占5.8%。
主要发现
- 58.4%的受访者报告提供院内cTn检测,其中65.5%缺乏儿科特异性参考区间。
- 提供参考区间的受访者中,区间来源、数值限值和性别分层存在显著差异。
- 高敏cTn检测广泛可用,至少71%报告周转时间小于2小时。
- 临床医生指出儿科cTn检测的适应症范围广泛。
- 临床医生和实验室专业人员一致强调缺乏验证的儿科参考区间、明确临床指南和标准化检测指征是主要局限。
临床怎么用
- 儿科cTn检测结果解读需谨慎,因多数实验室缺乏儿科特异性参考区间。
- 临床应关注检测适应症,并推动建立验证的儿科参考区间和标准化指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Limited guidance on the use and interpretation of cardiac troponin (cTn) testing in pediatric populations has restricted its broader adoption, despite the significant burden of congenital and acquired cardiac conditions in children. This survey aimed to evaluate global availability, utilization patterns, and key challenges associated with cTn testing in laboratories and among clinicians serving pediatric patients. METHODS: The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Emerging Technologies in Pediatric Laboratory Medicine (C-ETPLM) conducted an electronic survey in 2025. Distributed to IFCC members and their networks over one month, the survey included 19 questions targeting both laboratory professionals and clinicians involved in pediatric care. RESULTS: A total of 439 responses were collected from 48 countries spanning all continents, with 330 meeting eligibility criteria. Most respondents were laboratory specialists; clinicians represented 5.8 %. Among the 58.4 % who reported offering in-house cTn testing, 65.5 % lacked pediatric-specific reference intervals. Among those providing intervals, considerable variability existed in derivation, numerical limits, and sex-specific stratification. High-sensitivity cTn assays were widely available, and at least 71 % reported turnaround times under 2 hours. Clinicians indicated a broad range of indications for cTn testing in pediatric patients. Both clinicians and laboratory professionals consistently highlighted the lack of validated pediatric reference intervals, clear clinical guidelines, and standardized testing indications as major limitations. CONCLUSIONS: The absence of robust, outcome-based pediatric reference intervals, alongside limited clinical guidance and interpretive frameworks, remains a critical barrier to the effective and appropriate use of cardiac troponin testing in pediatric practice worldwide.
引用
- Omosule CL, Lang T, Geaghan SM, et al. Mapping pediatric cardiac troponin testing worldwide: results from the IFCC survey on emerging applications, standardization needs and access. Clin Chem Lab Med. 2026. PMID: 42543714. doi:10.1515/cclm-2026-0711
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。